Thursday, 29 June 2017

Generics News

  • Aurobindo recalls epilepsy drug lot in US

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 25 Nov, 2014

    Singapore: India-based Aurobindo Pharma in the US is recalling Gabapentin capsules, USP 300 mg 100-count bottles, at consumer level due to possible stashs of some empty capsules. USFDA has...Read more

  • Wockhardt restructures quality control team

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2013

    Singapore: After being rapped by the US FDA and Indian drug regulator for lapses in good manufacturing practices (GMP), Indian drug major Wockhardt has now restructured its quality control ...Read more

  • GSK officials under criminal investigation in China

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013

    Singapore: The Chinese police who have been investigating allegations of bribery against senior executives working at UK's leading multinational pharmaceutical company GlaxoSmithKline in Ch...Read more

  • Pneumonia kills a 5-year-old child every 30 secs: UN

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013

    Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of more than one million girls and boys every year. However, the good n...Read more

  • Sanofi files first-of-a-kind suit against FDA

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2013

    Singapore: Sanofi has filed a lawsuit against the US FDA in hopes of preventing the regulatory agency from releasing packaging information of its newly approved over-the-counter (OTC) aller...Read more

  • “Chinese generics market has no strategy for international players”

    Generics |  Influencers | By BioSpectrum Bureau | 0 Comment | 17 Nov, 2014

    Singapore: In the last one year, Actavis has been aggressive in expanding its presence in Asia and the company was on an acquisition spree. Marking a direct presence in Asia, Actavis launch...Read more

  • US FDA imposes import alert on Ranbaxy drugs

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2013

    Singapore: The US FDA has issued an alert on import of Ranbaxy Laboratories drug products that are manufactured at its plant in Mohali, India. The firm will remain on the import alert unt...Read more

  • Apollo Pharmacy cautions against Ranbaxy drugs' use

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2013

    New Delhi: Spelling further problems for India's pharma giant Ranbaxy and its Japanese owners Daiichi Sankyo, Apollo Pharmacy has issued a 'cautionary advisory' against the use of all drugs...Read more

  • Asian generic companies focus more on market expansion

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 25 Apr, 2015

    Singapore: A Frost & Sullivan (F&S) analysis finds that the Asian generic market is expected to grow at a compound annual growth rate of 17-18 percent between 2014 and 2018. The tea...Read more

  • Taiwan's TWi to independently hit the US market

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 26 Feb, 2015

    Singapore: Taiwan-based TWi Pharmaceuticals has decided to sell its products in the US market through its own US subsidiary, instead of the original plan of selling through Teva Pharmaceuti...Read more

  • Comply or face action: US FDA tells Indian drugmakers

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 29 Jul, 2013

    Singapore: With increasing number of non-compliance issues being logged against Indian drugmakers by the US FDA, this time the American regulatory body has instructed the companies to eithe...Read more

  • Dr. Reddy's launches generic Finasteride

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2013

    Hyderabad: Dr. Reddy's Laboratories has launched Finasteride tablets (1 mg), a bioequivalent generic version of Propecia (Finasteride) in the US market on January 02, 2013. Dr. Reddy's A...Read more

  • Suzhou Amerigen launches Mecobalamin in China

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2014

    Singapore: US-based Amerigen Pharmaceuticals' Chinese subsidiary, Suzhou Amerigen Pharmaceuticals has received Chinese FDA (CFDA) approval for its generic Mecobalamin 0.5 mg tablets. The co...Read more

  • ANI pharma acquires 22 generic drug from Teva

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2015

    Singapore: US based ANI Pharmaceuticals has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for USD25 million in cash and a percentage of future gross profit...Read more

  • Patents rights in India unreasonably denied: US Pharma

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2013

    Singapore: Expressing grave concern over the deteriorating intellectual property environment in India, the Pharmaceutical Research and Manufacturers of America (PhRMA) have said that the si...Read more

  • Sun Pharma cancer drug to address shortage

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2013

    Singapore: The US Food and Drug Administration has approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) made by Indian generics drug ma...Read more

  • Prasco Lab to market generics version of Colcrys in US

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 13 Jan, 2015

    Singapore: US generics firm, Prasco Laboratories, has entered into alliance with US subisdiary of Japanese pharmaceutical compamy, Takeda, to distribute Colchicine tablets, the generic vers...Read more

  • Jubilant smoking cessation aid gets FDA nod

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 21 Oct, 2013

    Singapore: India's leading pharma company, Jubilant Life Sciences received an approval from the US FDA for its anti-depressant drug, Bupropion Hydrochloride. The company said in a statemen...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls